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Abstract 
Leptin is a small peptide hormone that is mainly produced in adipose tissues. Leptin plays an 
important role in regulating appetite and energy expenditure and may be involved in modulating 
bone mineralization. The relationship between leptin and bone mineral density and bone 
biochemical parameters in not completely understood. This study was designed to examine the 
relationship between some biochemical parameters such as alkaline phosphatase (ALP), 
phosphorus (P), intact parathormone (iPTH) and calcium (Ca) with serum leptin level in renal 
transplant recipients. We studied 72 renal transplant patients (47 men and 25 women) with mean 
ages of 44 (± 12) years and mean body mass index (BMI) of 24.2 ± 3.9Kg/m² .Serum Ca, P, 
ALP, iPTH and serum leptin were measured. In this study a significant difference of serum leptin 
between males and females with higher values in females was seen. In patients a significant 
positive correlation of serum leptin with serum iPTH was found. There was not relationship 
between serum leptin with ALP, P, Ca, BMI, age and creatinine clearance. A negative 
relationship between serum leptin and the duration of kidney transplantation was found. Positive 
relationship of serum leptin with serum parathormone suggests that leptin may affect bone 
metabolism in renal transplant patients. 
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Introduction 
Renal transplantation (RT) is a treatment of choice for patients with end-stage kidney diseases 
[1-5]. Kidney transplantation corrects most of the metabolic disorders [4,5]. Post-transplant bone 
disease is a heterogeneous disease with various effects of age, gender, persistent 
hyperparathyroidism, corticosteroids and therapy with calcineurin inhibitors [4-10]. Leptin is 
released from fat tissues and circulating levels of leptin have been shown to be positively 
associated with fat mass in both lean and obese individuals [10,11]. Previous studies have shown 
elevated serum leptin levels in renal failure patients [12]. Leptin level is increased before 
transplantation, and decreased in the first year of RT [13]. Increase in serum leptin level may be 
seen thereafter and may be due to increase in fat mass, insulin resistance or steroid use in kidney 
transplant patients [14]. Leptin first emerged as a component of a regulatory fat mass and energy 
expenditure but recent evidence showed that leptin might be a potential mediator of the 
protective effects of fat mass on bone tissues [14,15]. Both a peripheral and a central action of 
leptin on bone have been proposed. Peripherally, leptin is found to exert positive effects on bone 
formation, whereas it is thought to reduce bone formation through a central control mechanism 
when binds to its specific receptors located on the hypothalamic nuclei [16-19]. However, the 
exact role of leptin on bone metabolism has not yet been clarified. It seems that leptin has the 
ability to affect directly the bone remodeling by modulating both osteoblast and osteoclast 
activities [17-19]. This study was desgined to evaluate the association between various indices of 
bone turn-over with serum leptin level in kidney transplant patients. 
Material and Methods 
Patients 
This cross-sectional study was conducted on a group of stable kidney transplant patients, referred 
to the clinic of nephrologyto continue their treatment. All patients signed the consent form for 
participation in this study. The etiologies of renal failure were diabetic nephropathy, 
hypertension, various glomerular diseases, autosomal dominant poly cystic kidney disease 
(ADPKD) or urinary tract infections [20-27]. Exclusion criteria included presence of acute 
rejection, any active or chronic infection, taking antibiotics during the past two months, and 
taking medications such as non steroidal anti-inflammatory drugs. After admission, all patients 
were examined for blood pressure (BP) and body mass index. Patients' histories concerning the 
length of the time that they were undergone kidney transplantation and their treatments were also 
obtained.Body mass index (BMI) was calculated using the standard formula (weight in 
kilograms/height in square meters) [28]. 
The basic immunosuppressive regimen of the recipients consisted of a combination of 
Cyclosporine at a mean dosage of 190 ± 60mg/day (median=200 mg/day), Prednisolon 7.5 
mg/day for all of the patients and Mycophenolate mofetile in 46% of the patients at a dosage of 
1500 ± 500 mg/day (median=1500 mg/day)/or Azathioprine at a dosage of 50 to 100 mg/day in 
the rest of the patients. Also patients were under treatment of Calcium carbonate and active 
vitamin D3 (Calcitriol; Rocaltrol) at various doses. 
Laboratory methods 
Serum leptin was measured as follows; blood samples were drawn after an overnight fasting, and 
centrifuged within 15 minutes of drawing. The levels were measured Serum leptin was measured 
as follows; blood samples were drawn after an overnight fasting, and centrifuged within 15 
minutes of drawing. The levels were measured by an enzyme-linked immunosorbent assay 
(ELISA) method using DRG kit (DRG diagnostic, Berline, Germany). Serum leptin normal 
rangefor males was considered to be 3.84 (± 1.79) and for females 7.36 (± 3.73) ng/mL. Intact 
parathormone (iPTH) was measured by radioimmunoassay method (normal range, 10-65 
pg/mL). After an overnight fast peripheral venous blood samples were collected for biochemical 
analysis including serum creatinine (Cr), blood urea nitrogen (BUN), albumin (Alb), serum 
magnesium (Mg), phosphorus (P), calcium (Ca), alkaline phosphatase (ALP) and serum albumin 
(Alb) levels, using standard kits. Creatinine clearance was evaluated from serum creatinine, 
considering age and body weight [29]. 
Statistical Analysis 
The results were expressed as the mean ± SD and median values. A statistical correlation was 
assessed using a partial correlation test. Comparison between groups were done using student’s t 
test. For normalization of the iPTH and leptin data, their second square were used. All statistical 
analyses were performed with the SPSS statistical package (version 11.500 for Windows; SPSS, 
Chicago, USA). Statistical significance was determined at a Pvalue < 0.05. 
Results 
A total of 72 patients were enrolled in this study, including 47 men, 25 women, in whom, 11 
patients had diabetes mellitus. The mean patients’ age was 44 (± 12) years. The mean length of 
the time that they had received a transplant kidney was 67.5 (± 42) months (median: 62 years). 
The patients data are shown in table 1. In this study there was a significant difference of serum 
leptin between females and males (r< 0.001; Figure 1). There was no significant difference of 
serum leptin between diabetic and non diabetic patients. In this study, there was a negative 
relationship between serum iPTH and creatinine clearance (r=- 0.44 P< 0.001). There was not 
any correlation between the duration of renal transplantation and serum iPTH (P>0.05). 
 Table 1: Data of the patients 
 
Figure 1: Significant difference of serum leptin between females and males 
There were inverse correlations of serum ALP with age (r=-0.35 P= 0.02) and duration of kidney 
transplantation (r=-0.29, P= 0.01). In this study, there was an inverse association between serum 
leptin and duration of renal transplantation (r=-0.26, P= 0.03; Figure 2). There was not any 
significant association between serum leptin and creatinine clearance, BMI or ages of the 
patients (P> 0.05). In this study, we also found a positive association between serum leptin and 
serum iPTH (r=0.24, P= 0.03; Figure 3). The association of serum leptin with serum Ca, P and 
ALP was not significant (P> 0.05). 
 
Figure 2: Inverse association between serum leptin and duration of renal transplantation 
 Figure 3: Positive association between serum leptin and serum iPTH 
Discussion 
In the current study we found a significant difference of serum leptin between females and 
males, while there was no significant difference of serum leptin between diabetic and non-
diabetic patients. There was a negative relationship between serum iPTH and creatinine 
clearance, however, there was not any correlation between the duration of renal transplantation 
and serum iPTH. There was inverse correlation between the serum ALP and age of the patients 
or duration of kidney transplantation. There was an inverse association between serum leptin and 
duration of renal transplantation. There were not any significant association between serum 
leptin and creatinine clearance or age of the patients. This study showed also a positive 
association between serum leptin and serum iPTH and finally the association of serum leptin 
with serum Ca, P and ALP was not significant. 
This study used the association between parathyroid hormone and serum leptin to define bone 
turn over in kidney transplant patients. Evenepoel et al. studied 1332 kidney allograft recipients, 
transplant between 1989 and 2000 [30]. They found that 4.1% of their patients had persistent 
hyperparathyroidism and needed parathyroidectomy after a first successful kidney 
transplantation. They concluded that persistent hyperparathyroidism requiring parathyroidectomy 
after successful kidney transplantation is a common clinical problem [30]. While in the present 
study our results are different, the patients’ mean iPTH being 18.4 (± 8.2) pg/mL (median: 16.5 
pg/mL) means there was not any persistent hyperparathyroidism. Studies have shown that 
parallel changes in body weight and bone mass can be partially mediated via circulating leptin. 
Among the hormones involved in bone and mineral metabolism, such as oestrogens, testosterone 
and parathormone, leptin has recently become a subject of considerable interest [31-35]. It is 
thought that in kidney transplant recipients, serum leptin levels are often elevated and bone 
mineral density (BMD) decreased [31-35]. Souza et al. carried out a study on thirty-two RT 
patients and found no correlation between leptin and renal function in their study. They showed 
also that during the first post transplant year, serum leptin levels decreased significantly in 
relation to pre-transplant period [13]. Published data ex plaining leptin effects on bone 
metabolism remain conflicting, with positive and negative effects [14,15,31-35]. It has been 
shown that increased fat is accompanied by greater serum leptin concentrations, bone mineral 
mass and a lower risk of osteoporosis [36-42]. Malnutrition reduces serum leptin concentrations 
and bone mineralization in men [43-50]. It was also found that both serum leptin concentrations 
and bone mineral are increased at the initiation of puberty [45-54]. These findings show that 
leptin may modulate bone mineral. Steppan et al. showed in young ob/ob mice that treatment 
with leptin elevates bone size, bone mineral content, and density, indicating that leptin is needed 
for bone growth and modeling [55]. 
Previously we conducted a study on a group of hemodialysis patients. We found a significant 
positive correlation of serum leptin with iPTH. We concluded that in hemodialysis patients 
serum leptin may affect bone activity [56]. Agras et al. found that elevated leptin level is 
associated with increased bone mass at lumbar sites in renal transplant recipients. This finding 
showed that increased leptin might have a bone-sparing effect, especially in the lumbar region, in 
RT patients [57]. In a study on 27 kidney allograft recipients, Malyszko et al. studied markers of 
bone turnover and leptin [58]. They found that leptin was correlated with the percentage of body 
fat, serum creatinine, and urea. They concluded that leptin levels were associated with graft 
function and body fat in kidney allograft recipients and leptin was not related to nutritional status 
or bone metabolism in kidney allograft recipients, but it was associated with the current dosage 
of immunosuppressant and the serum calcium [58]. Recently, in a study on a group of healthy 
women, Maetani et al. observed strong positive association between leptin and PTH levels [59]. 
In the present study, we tried to consider the interrelationship between serum leptin and bone 
turn over or parathyroid activity in a group of kidney transplant patients. Further studies are 
needed to clarify significance of our findings. 
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